Hormonal therapy considerations (GAHT, HRT)
Hormonal therapy in dental medicine matters primarily because of: (1) estrogen exposure (feminizing GAHT, HRT) → increased VTE (DVT/PE) risk, especially with oral formulations and in high-risk patients, (2) testosterone therapy (masculinizing GAHT) → can increase hematocrit/erythrocytosis and may affect thrombotic risk, and (3) spironolactone (antiandrogen in feminizing GAHT) → hyperkalemia risk. Key dental principle: hormones usually do not change antibiotic or analgesic selection, but they change peri-procedure VTE risk planning and comorbid medication awareness.
The full condition entry includes
- Safe vs avoid lists: antibiotics, analgesics, local anesthetics
- Vasoconstrictor limits and treatment modifications
- Pre/intra/post-op monitoring and deferral criteria
- Emergency management, explained for study
More medical conditions in dentistry
Dentalverse is an educational resource for dental students and dentists. This page is a study reference — it is not medical advice and does not replace clinical judgment. Always follow your institution's protocols and your supervisor's guidance.